Journal article · 2013 · Open access

Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence

Yi Luo, Lei Li, Ping Zou, Jie Wang, Lijian Shao, Daohong Zhou, Lingbo Liu

Transplantation, 97(1), 20–29 · Published 3 October 2013 · DOI 10.1097/tp.0b013e3182a7fcf8

Open full textView at the publisherCite this paper

In brief

“Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence” is a 2013 journal article by Yi Luo and 6 co-authors, published in Transplantation. OpenAlex counts 79 citations as of 20 November 2026, which puts it in the top 8% of works published in 2013 by citations. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
79
Most cited in
2021 (9)
Field-weighted impact
4.41
References
26
Authors
7

Abstract

BACKGROUND: The mammalian target of rapamycin (mTOR) is an important regulator of hematopoietic stem cell (HSC) self-renewal and its overactivation contributes to HSC premature exhaustion in part via induction of HSC senescence. Inhibition of mTOR with rapamycin has the potential to promote long-term hematopoiesis of ex vivo expanded HSCs to facilitate the clinical application of HSC transplantation for various hematologic diseases. METHODS: A well-established ex vivo expansion system for mouse bone marrow HSCs was used to investigate whether inhibition of overactivated mTOR with rapamycin can promote long-term hematopoiesis of ex vivo expanded HSCs and to elucidate the mechanisms of action of rapamycin. RESULTS: HSC-enriched mouse bone marrow LSK cells exhibited a time-dependent activation of mTOR after ex vivo expansion in a serum-free medium supplemented with stem cell factor, thrombopoietin, and Flt3 ligand. The overactivation of mTOR was associated with induction of senescence but not apoptosis in LSK cells and a significant reduction in the ability of HSCs to produce long-term hematopoietic reconstitution. Inhibition of overactivated mTOR with rapamycin promoted ex vivo expansion and long-term hematopoietic reconstitution of HSCs. The increase in long-term hematopoiesis of expanded HSCs is likely attributable in part to rapamycin-mediated up-regulation of Bmi1 and down-regulation of p16, which prevent HSCs from undergoing senescence during ex vivo expansion. CONCLUSIONS: These findings suggest that mTOR plays an important role in the regulation of HSC self-renewal in vitro and inhibition of mTOR hyperactivation with rapamycin may represent a novel approach to promote ex vivo expansion and their long-term hematopoietic reconstitution of HSCs.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Luo, Y., Li, L., Zou, P., Wang, J., Shao, L., Zhou, D., & Liu, L. (2013). Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence. Transplantation, 97(1), 20–29. https://doi.org/10.1097/tp.0b013e3182a7fcf8

MLA 9

Luo, Yi, et al. “Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence.” Transplantation, vol. 97, no. 1, 2013, pp. 20–29. https://doi.org/10.1097/tp.0b013e3182a7fcf8.

Chicago

Luo, Yi, Lei Li, Ping Zou, Jie Wang, Lijian Shao, Daohong Zhou, and Lingbo Liu. 2013. “Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence.” Transplantation 97 (1): 20–29. https://doi.org/10.1097/tp.0b013e3182a7fcf8.

Harvard

Luo, Y. et al. (2013) ‘Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence’, Transplantation, 97(1), pp. 20–29. doi:10.1097/tp.0b013e3182a7fcf8.

IEEE

Y. Luo et al., “Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence,” Transplantation, vol. 97, no. 1, pp. 20–29, 2013, doi: 10.1097/tp.0b013e3182a7fcf8.

BibTeX

@article{luo2013rapamycin,
  title     = {{Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence}},
  author    = {Luo, Yi and Li, Lei and Zou, Ping and Wang, Jie and Shao, Lijian and Zhou, Daohong and Liu, Lingbo},
  journal   = {Transplantation},
  year      = {2013},
  volume    = {97},
  number    = {1},
  pages     = {20--29},
  doi       = {10.1097/tp.0b013e3182a7fcf8},
  url       = {https://doi.org/10.1097/tp.0b013e3182a7fcf8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201766
201844
201966
202088
202199
202266
202333
202422
202544
202666

Its field-weighted citation impact is 4.41: it has been cited 4.41 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation

  • rapamycin
  • mTOR
  • hematopoietic stem cells
  • ex vivo HSC expansion
  • HSC self-renewal
  • BMI1
  • p16
  • LSK cells

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Luo, Y., Li, L., Zou, P., Wang, J., Shao, L., Zhou, D., & Liu, L. (2013). Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence. Transplantation, 97(1), 20–29. https://doi.org/10.1097/tp.0b013e3182a7fcf8

How many times has this paper been cited?

79 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Who wrote this paper?

Yi Luo, Lei Li, Ping Zou, Jie Wang, Lijian Shao, Daohong Zhou, Lingbo Liu.

What is the DOI of this paper?

10.1097/tp.0b013e3182a7fcf8, permanently at https://doi.org/10.1097/tp.0b013e3182a7fcf8. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.